Properties of Heparin sodium Anticoagulant: white amorphous powder, odorless, soluble in water, moisture absorption, average molecular weight 15000, stable at room temperature. Company potency ≥150IU/mg, anhydrous potency ≥160IU/mg. Other indexes are controlled according to API standards.
Heparin sodium anticoagulant application:
1. This product is suitable for blood sample collection and anticoagulation of clinical biochemical examination and emergency biochemical examination, as well as blood sample collection and anticoagulation of some hemorheology items.
2. Heparin is recommended as an anticoagulant for the determination of ions in the blood during clinical examinations, as it is least likely to interfere with the determination of other ions.
3. This product is not a medicine and cannot be used as an injection. Direct injection into humans and animals is prohibited.
In order to ensure adequate anticoagulation of blood, blood must be mixed upside-down for 5-8 times as soon as possible after blood collection, especially when the ambient temperature of blood collection is higher than 25℃, blood and heparin must be fully mixed in time, otherwise blood coagulation or local coagulation is easy to occur.
Heparin anticoagulant is irreversible, so the test of heparin anticoagulant tube should be completed within 6h after blood collection, otherwise it may lead to error of test results.
Heparin may be involved in the metabolism of cellular enzymes and ions, so the amount of heparin may affect the test results. The dosage of heparin should ensure sufficient anticoagulation in all and local samples to ensure that most of the plasma indicators can be repeated within 6 hours, especially sensitive indicators such as AST, ALT, TBIL, DBIL and GGT.
Heparin can be used in conjunction with the separation gel. Anticoagulation effect, silification of tube wall, centrifugal conditions, quality of separated gel, etc. Can affect blood separation. It is suggested to use with the blood separation gel produced by our company to obtain high quality plasma samples.
Irradiation sterilization after vascular collection is recommended: γ -ray irradiation with a dose of 8-25Gy. The radiation dose may be determined by the initial colony count.